Divestment
Okairos
Okairos developed T-cell vaccines for infectious diseases and cancer.
Key Facts
- Sector
Life Sciences
- Country
Switzerland
- Fund
LSP 3
- Entry
2007
- Exit
2014
Responsible Partner
Do You Want to Know More?
We are eager to explore how we can achieve great things together.